Optimind Pharma Statistics

Total Valuation

Optimind Pharma has a market cap or net worth of CAD 515,742. The enterprise value is 530,092.

Market Cap	515,742
Enterprise Value	530,092

Important Dates

The next estimated earnings date is Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Optimind Pharma has 103.15 million shares outstanding. The number of shares has increased by 3.99% in one year.

Current Share Class	103.15M
Shares Outstanding	103.15M
Shares Change (YoY)	+3.99%
Shares Change (QoQ)	-4.72%
Owned by Insiders (%)	3.29%
Owned by Institutions (%)	n/a
Float	99.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.74
PB Ratio	-7.44
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.47
EV / Sales	3.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.58

Current Ratio	0.58
Quick Ratio	0.58
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.22%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	151.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.59
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	0.16
52-Week Price Change	n/a
50-Day Moving Average	0.01
200-Day Moving Average	0.01
Relative Strength Index (RSI)	21.42
Average Volume (20 Days)	2,316

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Optimind Pharma had revenue of CAD 138,024 and -118,605 in losses. Loss per share was -0.00.

Revenue	138,024
Gross Profit	90,061
Operating Income	-105,019
Pretax Income	-118,605
Net Income	-118,605
EBITDA	n/a
EBIT	-105,019
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 106,289 in cash and 120,637 in debt, giving a net cash position of -14,348 or -0.00 per share.

Cash & Cash Equivalents	106,289
Total Debt	120,637
Net Cash	-14,348
Net Cash Per Share	-0.00
Equity (Book Value)	-69,323
Book Value Per Share	-0.00
Working Capital	-119,323

Full Balance Sheet

Cash Flow

Operating Cash Flow	-309,812
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 65.25%, with operating and profit margins of -76.09% and -85.93%.

Gross Margin	65.25%
Operating Margin	-76.09%
Pretax Margin	-85.93%
Profit Margin	-85.93%
EBITDA Margin	n/a
EBIT Margin	-76.09%
FCF Margin	n/a

Dividends & Yields

Optimind Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.99%
Shareholder Yield	n/a
Earnings Yield	-23.00%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Optimind Pharma has an Altman Z-Score of -32.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-32.74
Piotroski F-Score	3